
Science Resources RSS Feeds
|
 |
 |
 |
Effects of bacterial pneumonia no worse for HIV-positive patients
September 28, 2005
Pneumonia doesn't appear to harm HIV-positive patients any more than those without HIV, according to a new international study conducted in part by the University of Alberta. In a two-year study that documented cases in 26 hospitals in 11 countries including the United States, Canada, South Africa, Chile and Spain, outcomes for 58 HIV-positive patients with CAP, or community-acquired pneumonia (pneumonia contracted outside of hospitals) were compared with outcomes for 174 HIV-negative patients suffering a similar severity of CAP. All the HIV-positive and negative patients were matched for age and gender. No differences were found in the length of hospitalization or in the time it took to clinically stabilize the patients. There was also negligible difference in the mortality rate; total deaths among the HIV patients was 3.5 per cent (two of 58 patients), and 4.8 per cent (seven of 174) among the HIV-negative patients.
Patients with Pneumocystis infection were excluded, as the study was designed to address those with bacterial infections.
Results of the study appeared recently in the journal Clinical Infectious Diseases.
The findings should benefit HIV-positive patients in two ways, Dr. Marrie said. "Patients with less severe pneumonia may be hospitalized less if physicians know that their HIV infection won't put them at any additional risk of complications." This study also emphasizes the benefits of treatment of HIV. Control of HIV infection improves the health of patients and they get infections such as bacterial pneumonia less frequently. "When they do get bacterial pneumonia, their immune systems are better able to respond to the infection."
University of Alberta
|
 |
Related Bacterial Pneumonia Current Events and Bacterial Pneumonia News Articles Bacterial Pneumonia Current Events and Bacterial Pneumonia News RSS How much is the world spending on neglected disease research and development? The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total.
Pathogenic soil bacterium is influenced by land management practices Researchers from Menzies School of Health Research in Darwin, Australia have found that the soil bacterium Burkholderia pseudomallei, which causes the emerging infectious disease melioidosis in humans and animals, is associated with land management changes such as livestock husbandry or residential gardening.
From poison to prevention One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don't cause illness. Trickier still is to ensure that such weapons against infectious disease can be safely disarmed, once their immunogenic work is done.
Study finds more effective treatment for pneumonia following influenza Scientists at St. Jude Children's Research Hospital have demonstrated a more effective treatment for bacterial pneumonia following influenza.
Gene therapy effective treatment against gum disease Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
Steroids aid recovery from pneumonia, UT Southwestern researchers say Adding corticosteroids to traditional antimicrobial therapy might help people with pneumonia recover more quickly than with antibiotics alone, UT Southwestern Medical Center scientists have found.
Bacterial pneumonia caused most deaths in 1918 influenza pandemic The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Despite vaccine, public should not get complacent about pneumococcal disease Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston.
Immune deficiency and balance disorder result from single gene defect A genetic defect that causes a severe immune deficiency in humans may also produce balance disorders, according to a new study by researchers at the University of Iowa, The Jackson Laboratory and East Carolina University.
Children's Hospital scientists identify possible target for prevention and treatment of pneumonia Researchers at Children's Hospital of Pittsburgh of UPMC have identified a key protein target that may be a crucial factor in the development of a vaccine to prevent and new therapies to treat pneumonia, the leading killer of children worldwide. More Bacterial Pneumonia Current Events and Bacterial Pneumonia News Articles
|
 |

|
Pneumonia: Bacterial pneumonia, Viral pneumonia, Fungal pneumonia, Parasitic pneumonia, Atypical pneumonia, Community-acquired pneumonia
by John McBrewster (Editor), Frederic P. Miller (Editor), Agnes F. Vandome (Editor)
Pneumonia is an inflammatory illness of the lung. Frequently, it is described as lung parenchyma/alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation). The alveoli are microscopic air-filled sacs in the lungs responsible for absorbing oxygen. Pneumonia can result from a variety of causes, including infection with bacteria, viruses, fungi, or parasites, and chemical or physical injury to the lungs. Its cause may also be officially described as idiopathic? that is, unknown?when infectious causes have been excluded. Typical symptoms associated with pneumonia include cough, chest pain, fever, and difficulty in breathing. Diagnostic tools include x-rays and examination of the sputum. Treatment depends on the cause of...
|

|
Antibiotic Resistance: Stopping the Superbugs
Directed By: ITV Also With: ITV (Producer)
|
|
|
PNEUMONIA, BACTERIAL AND VIRAL: An entry from Gale's World of Microbiology and Immunology
by Gale (Publisher)
This digital document is an article from World of Microbiology and Immunology, brought to you by GaleĀ®, a part of Cengage Learning, a world leader in e-research and educational publishing for libraries, schools and businesses. The length of the article is 1504 words. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Covers the concepts, theories, discoveries, and pioneers in microbiology and immunology, using a mix of traditional academic and topical articles, this title addresses current ethical, legal, and social issues with special emphasis given to biological warfare and terrorism.
|

|
Bacterial Pneumonia - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
by ICON Health Publications (Author)
In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most advanced tools available and spending the least amount of time doing so.
|
|
|
Seek clues to differentiate types of pneumonia. (Bacterial, Viral, and Atypical Etiologies).: An article from: Pediatric News
by Sharon Worcester (Author)
This digital document is an article from Pediatric News, published by International Medical News Group on April 1, 2003. The length of the article is 944 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Seek clues to differentiate types of pneumonia. (Bacterial, Viral, and Atypical Etiologies). Author: Sharon Worcester Publication: Pediatric News (Magazine/Journal) Date: April 1, 2003 Publisher: International Medical News Group Volume: 37 Issue: 4 Page: 12(1)
Distributed by Thomson...
|
|
|
Hospitalists and improved cost savings in patients with bacterial pneumonia at a state level.: An article from: Southern Medical Journal
by Danielle B. Scheurer (Author), Justin G. Miller (Author), Dwight I. Blair (Author), Pam J. Pride (Author), Gena M. Walker (Author), Patrick J. Cawley (Author)
This digital document is an article from Southern Medical Journal, published by Southern Medical Association on June 1, 2005. The length of the article is 2506 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Hospitalists and improved cost savings in patients with bacterial pneumonia at a state level. Author: Danielle B. Scheurer Publication: Southern Medical Journal (Magazine/Journal) Date: June 1, 2005 Publisher: Southern Medical Association Volume: 98 Issue: 6 Page: 607(4)
Distributed by Thomson...
|
|
|
Pathophysiology and laboratory identification of pneumonia.(CLINICAL LABORATORY MEDICINE): An article from: FOCUS: Journal for Respiratory Care & Sleep Medicine
by Don Steinert (Author)
This digital document is an article from FOCUS: Journal for Respiratory Care & Sleep Medicine, published by Focus Publications, Inc. on January 1, 2009. The length of the article is 1621 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Pathophysiology and laboratory identification of pneumonia.(CLINICAL LABORATORY MEDICINE) Author: Don Steinert Publication: FOCUS: Journal for Respiratory Care & Sleep Medicine (Magazine/Journal) Date: January 1, 2009 Publisher: Focus Publications, Inc. Page: 20(3)
Distributed by Gale, a part of Cengage...
|
|
|
Tools predict community pneumonia's course.(Infectious Diseases): An article from: Internal Medicine News
by Sherry Boschert (Author)
This digital document is an article from Internal Medicine News, published by Thomson Gale on January 1, 2007. The length of the article is 656 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Tools predict community pneumonia's course.(Infectious Diseases) Author: Sherry Boschert Publication: Internal Medicine News (Magazine/Journal) Date: January 1, 2007 Publisher: Thomson Gale Volume: 40 Issue: 1 Page: 34(1)
Distributed by Thomson...
|
|
|
Remicade[R] associated with risks of hepatotoxicity and pneumonia.(PIPELINE PREVIEWS): An article from: Journal of Drugs in Dermatology
by Journal of Drugs in Dermatology, Inc. (Publisher)
This digital document is an article from Journal of Drugs in Dermatology, published by Journal of Drugs in Dermatology, Inc. on March 1, 2005. The length of the article is 536 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Remicade[R] associated with risks of hepatotoxicity and pneumonia.(PIPELINE PREVIEWS) Publication: Journal of Drugs in Dermatology (Refereed) Date: March 1, 2005 Publisher: Journal of Drugs in Dermatology, Inc. Volume: 4 Issue: 2 Page: 251(2)
Distributed by Thomson...
|
|
|
Community-acquired pneumonia: help's coming. (New Antibiotics).: An article from: Family Practice News
by Sherry Boschert (Author)
This digital document is an article from Family Practice News, published by International Medical News Group on December 1, 2002. The length of the article is 565 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Community-acquired pneumonia: help's coming. (New Antibiotics). Author: Sherry Boschert Publication: Family Practice News (Magazine/Journal) Date: December 1, 2002 Publisher: International Medical News Group Volume: 32 Issue: 23 Page: 48(1)
Distributed by Thomson...
|
|